skin scarification of B.C.G., together with injections of irradiated leuLkaemic cells, prolongs chemotherapeutically induced remissions in acute lymphocytic (Mathe et al., 1969a (Mathe et al., , 1973 and mycloblastic (Powles et al., 1973) (Sokal, Aungst and Grace, 1973) . Repeated skin scarification of B.C.G. also prolongs survival of patients following surgical removal of melanoma (Gutterman et al., 1973; Bluming et al., 1972) . In addition, intralesional injections of B.C.G. restrict growth of surface melanomata (Morton et al., 1970; Bornstein et al., 1973; Pinsky, Hirshaut and Oettgen, 1973) and the feasibility of using intravenously injected B.C.G. in treatment of myeloblastic leukaemia has been indicated (Whittaker et al., 1973 Pinsky et al., 1973; Hunt et al., 1973) . Recently, Accepted 20 August 1974 however, it has been reported that administration of B.C.G. orally to patients with malignant melanoma produced beneficial effects in a few cases (Falk, Mann and Langer, 1973) . Orally administered B.C.G. is relatively non-toxic, more than 200 mg of vaccine being well tolerated clinically in immunization against tuberculosis (Leading article, 'ubercle, 1960) .
Particularly in view of the low toxicity and ease of administration, the tumour suppressive properties of B.C.G. given orally require experimental examination. The present studies were carried out to assess the influence of orally administered vaccine on intraperitoneal, pulmonary and metastatic growth of transplanted rat tumours.
MATERIALS AND METHODS
Tumours.-The tumours used were induced or arose spontaneously in rats of an inbred Wistar strain and maintained by subcutaneous transplantation in rats of the same sex as the primary donor. Sarcoma Mc57 was induced by subcutaneous implantation of 3-methyleholanthrene. Epithelioma Spi arose spontaneously and regularly produced pulmonary metastases from subcutaneous grafts, even following their surgical removal (Baldwin, 1966; Baldwin and Pimm, 1973a (Wexler, 1966 ) and the number of macroscopic nodules on the lung surface counted.
RESULTS
In 2 tests witlh the sarcoma Mca57, where ttumour cells (1 x 106) were injected intraperitoneally (Table I) The final test was carried out with the epithelioma Spl. Nine-day old subcutaneous grafts were surgically removed and animals then treated daily with 1 0 mg moist weight of B.C.G. until they had to be killed due to development of spontaneous pulmonary metastases. All (4/4) control rats survived for 28 davs and had macroscopically visible metastases (1, 27, 180, 200+ nodules/lung). Treated rats had to be killed after 26-28 days and all of these (5/5) also had pulmonary metastases (55, 90, 180, 200+, 200+ nodules/lung).
DISCUSSION
These studies establish that orally administered B.C.G. vaccine does not influence intraperitoneal or pulmonary growth of a transplanted rat sarcoma or restrict the development of post-surgical pulmonary metastases from a transplanted epithelioma.
The lack of effectiveness of comparatively large doses of B.C.G. administered orally contrasts markedly with the ability of the vaccine to suppress growth of tumours described in this paper when the vaccine is introduced directly into the environment of tumour growth. Thus, in the present studies daily oral administration of 0 5 mg of B.C.G. did not restrict intraperitoneal development of sarcoma Mc57, although a single injection of 100 ,ug of the vaccine directly into the peritoneal cavity completely suppresses tumour growth at this site (Pimm, 1974) . Also in contrast to the present findings, pulmonary tumour growth of sarcoma cells is completely abolished following the introduction of B.C.G. into pulmonary tissue by a single intravenous injection of the vaccine (Baldwin and Pimm, 1973c) . In addition, post-surgical pulmonary metastases of epithelioma Spl can be significantly reduced by repeated intravenous administration of B.C.G. (Baldwin and Pimm, 1973a ).
While general immunostimulation by nonspecific agents such as B.C.G. may be tumour suppressive in a number of experimental situations (Mathe, Pouillart and Lapeyraque, 1969b; Parr, 1972; Currie and Bagshawe, 1970; Woodruff and Boak, 1966) , many other recent studies have emphasized that direct contact between B.C.G. organisms and tumour cells produces a more marked suppression of tumour growth. Thus, syngeneic transplants of several tumours, including diethylnitrosamine induced guinea-pig hepatomata (Zbar, Bernstein and Rapp, 1971) and 3-methylcholanthrene induced rat and mouse sarcomata Pimm, 1971, 1973b; Bartlett, Zbar and Rapp, 1972) are suppressed when cells are injected locally in admixture with B.C.G., and intralesional injection of B.C.G. may retard growth of transplanted sarcomata (Baldwin and Pimm, 1971) , hepatomata (Zbar et al., 1972a) and primary mouse mammary carcinomata (Simmons, Rios and Kersey, 1972) . In addition, mixed inocula of tumour cells and B.C.G. organisms may be used for active immunotherapy of subcutaneous and pulmonary tumour deposits (Baldwin and Pimm, 1973b, c) .
The present findings do not rule out the possibility that a general immunostimulation may be produced by orally administered B.C.G. and this may have some beneficial clinical effects (Falk et al., 1973) . However, the indication is that in those situations where marked tumour suppression can be achieved by contact between tumour cells and B.C.G. this effect may be lost by administering B.C.G. orally, even in comparatively massive doses. It might, therefore, be unwise in those clinical situations where treatment by contact between malignant tissue and B.C.G. organisms is established to be suppressive, such as in melanoma, or where injections of B.C.G. and inactivated malignant cells are being used for active immunotherapy, to attempt to minimize toxic effects of B.C.G. by administering the vaccine orally. Adverse effects may perhaps be better eliminated by the use of non-living B.C.G. organisms or mycobacterial subcellular fractions. For instance, intact B.C.G. organisms sterilized by y irradiation (Baldwin et al., 1974) and mycobacterial methanol extraction residue (Weiss and Wells, 1960) retain tumour suppressive properties when contacted with malignant cells (Baldwin and Hopper, unpublished findings) , and B.C.G. cell wall fragments attached to oil droplet emulsions inhibit local tumour growth (Zbar, Rapp aind Ribi, 1972b ) and pulmonary metastases (Baldwin and Pimm, 1973d 
